Aghazadeh Behzad — SEC Form 4 filings
SEC reporting owner CIK 1701815. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-28.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-14 to 2026-07-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 1 filing — 2,391,238 shares, $36,259,761 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: purchase of 2,333,333 shares @ $15.00 ($34,999,995) in Scribe Therapeutics, Inc., filed 2026-07-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Scribe Therapeutics, Inc. (SCTX) | Director, 10% owner | 2 | 3 legs · 2,391,238 sh · $36,259,761 | — | 1 |
| Whitehawk Therapeutics, Inc. (WHWK) | Director, 10% owner | 5 | — | — | 5 |
Form 4 filings — Aghazadeh Behzad
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-28 | 4 | Scribe Therapeutics, Inc. (SCTX) jointly with Avoro Capital Advisors LLC, Avoro Ventures LLC | Purchase (P): 2,333,333 @ $15 · Purchase (P): 50,000 @ $22.31 · Purchase (P): 7,905 @ $18.25 | EDGAR |
| 2026-07-27 | 4 | Scribe Therapeutics, Inc. (SCTX) jointly with Avoro Capital Advisors LLC, Avoro Ventures LLC | Grant/award (A): 14,725 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Whitehawk Therapeutics, Inc. (WHWK) jointly with Avoro Capital Advisors LLC, Avoro Ventures LLC | Grant/award (A): 38,040 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Whitehawk Therapeutics, Inc. (WHWK) jointly with Avoro Capital Advisors LLC, Avoro Ventures LLC | Grant/award (A): 6,377,714 (derivative) @ $3.92 | EDGAR |
| 2025-06-16 | 4 | Whitehawk Therapeutics, Inc. (WHWK) jointly with Avoro Capital Advisors LLC, Avoro Ventures LLC | Grant/award (A): 40,006 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Aadi Bioscience, Inc. (AADI) jointly with Avoro Capital Advisors LLC, Avoro Ventures LLC | Grant/award (A): 8,333,000 (derivative) @ $2.40 | EDGAR |
| 2024-06-14 | 4 | Aadi Bioscience, Inc. (AADI) jointly with Avoro Capital Advisors LLC, Avoro Ventures LLC | Grant/award (A): 45,832 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1701815 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →